These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 28967519)
1. Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells. Forero A; Fenstermacher K; Wohlgemuth N; Nishida A; Carter V; Smith EA; Peng X; Hayes M; Francis D; Treanor J; Morrison J; Klein SL; Lane A; Katze MG; Pekosz A Vaccine; 2017 Oct; 35(45):6112-6121. PubMed ID: 28967519 [TBL] [Abstract][Full Text] [Related]
2. Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures. Fischer WA; Chason KD; Brighton M; Jaspers I Vaccine; 2014 Mar; 32(15):1761-7. PubMed ID: 24486351 [TBL] [Abstract][Full Text] [Related]
3. Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells. Fischer WA; King LS; Lane AP; Pekosz A Vaccine; 2015 Aug; 33(36):4495-504. PubMed ID: 26196325 [TBL] [Abstract][Full Text] [Related]
5. The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells. Wohlgemuth N; Ye Y; Fenstermacher KJ; Liu H; Lane AP; Pekosz A Vaccine; 2017 Dec; 35(48 Pt B):6691-6699. PubMed ID: 29079099 [TBL] [Abstract][Full Text] [Related]
6. The role of nasal IgA in children vaccinated with live attenuated influenza vaccine. Ambrose CS; Wu X; Jones T; Mallory RM Vaccine; 2012 Nov; 30(48):6794-801. PubMed ID: 23000125 [TBL] [Abstract][Full Text] [Related]
7. Differential interferon responses to influenza A and B viruses in primary ferret respiratory epithelial cells. Rowe T; Davis W; Wentworth DE; Ross T J Virol; 2024 Feb; 98(2):e0149423. PubMed ID: 38294251 [TBL] [Abstract][Full Text] [Related]
8. A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses. Rodriguez L; Nogales A; Murcia PR; Parrish CR; Martínez-Sobrido L Vaccine; 2017 Aug; 35(34):4374-4381. PubMed ID: 28709557 [TBL] [Abstract][Full Text] [Related]
9. HA and M2 sequences alter the replication of 2013-16 H1 live attenuated influenza vaccine infection in human nasal epithelial cell cultures. Canaday LM; Resnick JD; Liu H; Powell H; McCoy AM; Nguyen D; Pekosz A Vaccine; 2022 Jul; 40(32):4544-4553. PubMed ID: 35718589 [TBL] [Abstract][Full Text] [Related]
11. A Co-culture Model of PBMC and Stem Cell Derived Human Nasal Epithelium Reveals Rapid Activation of NK and Innate T Cells Upon Influenza A Virus Infection of the Nasal Epithelium. Luukkainen A; Puan KJ; Yusof N; Lee B; Tan KS; Liu J; Yan Y; Toppila-Salmi S; Renkonen R; Chow VT; Rotzschke O; Wang Y Front Immunol; 2018; 9():2514. PubMed ID: 30467502 [No Abstract] [Full Text] [Related]
12. Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination. Mohn KGI; Zhou F; Brokstad KA; Sridhar S; Cox RJ J Infect Dis; 2017 May; 215(10):1527-1535. PubMed ID: 28368530 [TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers. Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566 [TBL] [Abstract][Full Text] [Related]
14. Human Nasal and Lung Tissues Infected Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170 [TBL] [Abstract][Full Text] [Related]
15. Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin. Basha S; Hazenfeld S; Brady RC; Subbramanian RA Hum Immunol; 2011 Jun; 72(6):463-9. PubMed ID: 21414368 [TBL] [Abstract][Full Text] [Related]
16. Changes in sialic acid binding associated with egg adaptation decrease live attenuated influenza virus replication in human nasal epithelial cell cultures. Powell H; Liu H; Pekosz A Vaccine; 2021 Jun; 39(24):3225-3235. PubMed ID: 33985852 [TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults. Block SL; Yi T; Sheldon E; Dubovsky F; Falloon J Vaccine; 2011 Nov; 29(50):9391-7. PubMed ID: 21983154 [TBL] [Abstract][Full Text] [Related]
18. Vaccine-specific antibody secreting cells are a robust early marker of LAIV-induced B-cell response in ferrets. Cherukuri A; Servat E; Woo J Vaccine; 2012 Jan; 30(2):237-46. PubMed ID: 22080173 [TBL] [Abstract][Full Text] [Related]
19. Live Attenuated Influenza Vaccines engineered to express the nucleoprotein of a recent isolate stimulate human influenza CD8 Korenkov D; Nguyen THO; Isakova-Sivak I; Smolonogina T; Brown LE; Kedzierska K; Rudenko L Hum Vaccin Immunother; 2018 Apr; 14(4):941-946. PubMed ID: 29252117 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets. Shen Z; Bowen RA; Ge P; Yu J; Shen Y; Kong W; Jiang C; Wu J; Zhu C; Xu Y; Wei W; Rudenko L; Kiseleva I; Xu F Vaccine; 2016 Nov; 34(48):5953-5958. PubMed ID: 27997342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]